Researchers develop a low-cost automated rapid test for detecting SARS-CoV-2 antibodies
During the continued progression of the Corona pandemic, rapid, inexpensive, and reliable tests will become increasingly important to determine whether people have the associated antibodies - either through infection or vaccination.
Michael Seidel Emily Henderson Technical University Of Munich Bavarian Research Foundation Department Of Analytical Chemistry Technical University
Source: news-medical.net